The Relationship Between High-Fat Diet and Fibronectın Type III Domaın Containing Protein 5 mRNA Expression

Year 2018, Volume: 23 Issue: 1, 1 - 5, 02.01.2018

Cemil Kahraman

https://doi.org/10.21673/anadoluklin.349294

Abstract

Aim:
Fibronectin
type III domain containing protein 5 (FNDC5) is located in both muscle and
brown adipose tissue. It is expressed that FNDC5
and irisin (fragment of FNDC5)  may be use as a therapeutic
molecule due to their effects for metabolic disease (related to obesity).
Since irisin/FNDC5, a membrane protein,  was recently revealed, there are limited
number of studies about them. The purpose of this
study was to assess the relationship between FNDC5 assosiated with
metabolic disease and high-fat diet in muscle and brown adipose tissue.

Materials
and Methods: In the study, 18 male Sprague-Dawley
rats, 1.5-2 months old were used. Rats were randomly chosen, and divided into 3
groups consisting of 6 rats.  Rats were
fed 85 days with low-fat standard diet or high-fat diet. In both the brown
adipose tissue and muscle tissue, FNDC5 mRNA
expressions were measured.

Results: When the FNDC5 mRNA levels of control and obese groups were compared, it
was determined that the FNDC5 mRNA levels of obese group was higher than that of the
control group in the brown adipose tissue (p=0.016). When the FNDC5 mRNA levels of antioxidant and obese groups were examined,
obese group’s levels was higher than that of the antioksidant group in the
brown adipose tissue (p=0.010). As for the muscle tissue,  FNDC5 mRNA levels
were determined to be lower in the antioxidant group than in the control group
(p=0.006).

Discussion and
Conclusion: Our study
indicated that FNDC5 mRNA expression changed in the brown
adipose tissue due to high-fat
diet, but doesn’t change in the muscle tissue. Therefore,  it is understood that high-fat
diet may be effective in the regulation of FNDC5 mRNA expression in BAT.

Keywords

Brown adipose tissue, FNDC 5, high-fat diet, obesity

Yüksek Yağlı Diyet Ve Fibronektin Tip III Domein İçeren Protein 5 mRNA Ekspresyonu Arasındaki İlişki

Abstract

Amaç:
Hem
kahverengi yağ dokusunda hemde kas dokusunda fibronektin tip III domein içeren
protein 5 (FNDC5) bol bulunur. FNDC5 ve FNDC5’in fragmenti olan irisinin
çeşitli etkilerinden dolayı obezite ile ilişkili metabolik hastalıkların
tedavisinde tedavi edici molekül olarak kullanılabileceği ifade edilmektedir. Membran
proteini olan FNDC5 ve irisin yakın zamanda bulunduğu için literatürde sınırlı
sayıda çalışma bulunmaktadır. Bu çalışmanın amacı kas ve kahverengi yağ
dokusunda yüksek yağlı diyet ve metabolik hastalıklarla ilişkili FNDC5 mRNA
ekspresyonu arasındaki ilişkiyi incelemektir.

Gereç
ve Yöntemler: Çalışmada 18 adet 1,5-2 aylık erkek
Sprague-Dawley sıçanlar rastgele her grupta 6 tane olacak şekilde 3 gruba
ayrıldı. Sıçanlar gruplarına özgü yemle 85 gün beslendi. Beslenme süresinin
bitiminde kas ve kahverengi yağ dokuları toplandı ve bu dokularda FNDC5 mRNA ekspresyon
ölçümleri yapıldı.

Bulgular:
Kontrol
grubu ile obez grubun FNDC5 mRNA seviyesi karşılaştırıldığında, kahverengi yağ
dokusunda obez grupta kontrol grubuna göre daha yüksekti (p=0.016). Obez grup
ile antioksidan grup karşılaştırıldığında ise, aynı dokuda obez grubun FNDC5
mRNA seviyesinin antioksidan gruptan daha yüksek olduğu tesbit edildi (p=0.010).
Kas dokusuna gelince, bu dokuda antioksidan grupta kontrol grubuna göre daha
düşük FNDC5 mRNA ekspresyonu ölçüldü (p=0.006).

Tartışma
ve Sonuç: Çalışmamız yüksek yağlı diyetin kahverengi yağ
dokusundaki FNDC5 mRNA ekspresyonunu değiştirdiğini fakat kas dokusunda
değiştirmediğini, bu nedenle yüksek yağlı diyetin kahverengi yağ dokusunda FNDC5
mRNA ekspresyonunun düzenlenmesinde
etkili olabileceği anlaşılmaktadır.

Keywords

Kahverengi yağ dokusu, FNDC 5, yüksek yağlı diyet, obezite

References

• 1. Wang CY, Liao JK. A Mouse Model of Diet-Induced Obesity and Insulin Resistance. Methods Mol Biol. 2013; 821, 421-433.
• 2. Kopelman PG. Obesity as a Medical Problem. Nature 2000; 404, 635–643.
• 3. Mitchell N, Catenacci V, Wyatt H R, Hill JO. Obesity: Overview of an Epidemic. Psychiatric Clinics of North America 2011; 34, 717–732.
• 4. Ouellet V, Labbe SM, Blondin DP, Phoenix S, Guerin B, Haman F, Turcotte EE, Richard D, Carpentier AC. Brown Adipose Tissue Oxidative Metabolism Contributes to Energy Expenditure During Acute Cold Exposure in Humans. Journal of Clinical Investigation 2012; 122, 545–552.
• 5. Kozak LP. Brown Fat and the Myth of Diet-Induced Thermogenesis Cell Metabolism 2010; 11, 263-267.
• 6. Teufel A, Malik N, Mukhopadhyay M, Westphal H. Frcp1 and Frcp2, Two Novel Fibronectin Type III Repeat Containing Genes. Gene 2002; 297, 79–83.
• 7. Ferrer-Martinez A, Ruiz-Lozano P, Chien KR. Mouse PeP a Novel Peroxisomal Protein Linked to Myoblast Differentiation and Development. Developmental Dynamics 2002; 224, 154–167.
• 8. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM. A PGC1-a-dependent Myokine That Drives Brown-Fat-Like Development of White Fat and Thermogenesis. Nature 2012; 481, 463-468. 9. Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, Idelson C, Perron RM, Werner CD, Phan GQ, Kammula US, Kebebew E, Pacak K, Chen KY, Celi FS. Irisin and FGF21 are Cold-İnduced Endocrine Activators of Brown Fat Function in Humans. Cell Metabolism 2014; 19, 302–309.
• 10. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernández-Real JM. Irisin is Expressed and Produced by Human Muscle and Adipose Tissue in Association with Obesity and Insulin Resistance. J Clin Endocrinol Metab. 2013; 98, e769-e778.
• 11. Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, Brockmann B, Jung R, Wisløff U, Tjønna AE, Raastad T, Hallén J, Norheim F, Drevon CA, Romacho T, Eckardt K, Eckel J. Evidence Against a Beneficial Effect of Irisin in Humans 2013; 8, e73680.
• 12. Elsen M, Raschke S, Eckel J. Browning of White Fat: Does Irisin Play a Role in Humans?. Journal of Endocrinology 2014; 222, R25–R38.
• 13. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and İrisin in Humans: I. Predictors of Circulating Concentrations in Serum and Plasma and II. mRNA Expression and Circulating Concentrations in Response to Weight Loss and Exercise. Metabolism clinical and experimental 2012; 1725-1738.
• 14. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Crujeiras AB, Seoane LM, Casanueva FF, Pardo M. FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine. Plos one 2013; 8, e60563.
• 15. Betz MJ, Bielohuby M, Mauracher B, Abplanalp W, Muller HH, Pieper K, Ramisch J, Tscho MH, Beuschlein F, Bidlingmaier M, Slawik M. Isoenergetic Feeding of Low Carbohydrate-High Fat Diets Does Not Increase Brown Adipose Tissue Thermogenic Capacity in Rats. PLoS One 2012; e38997.
• 16. Lira VA, Benton CR, Yan Z, Bonen. A PGC-1 regulation by exercise training and its influences on muscle function and insulin sensitivity. Endocrinology and Metabolism 2010; 299, e145-e161.